EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
We are looking for a new Chemistry curator to join the ChEBI team. Find out more about it here.
CHEBI:9622 - tolterodine
| Formula | C22H31NO |
| Net Charge | 0 |
| Average Mass | 325.496 |
| Monoisotopic Mass | 325.24056 |
| SMILES | Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1 |
| InChI | InChI=1S/C22H31NO/c1-16(2)23(17(3)4)14-13-20(19-9-7-6-8-10-19)21-15-18(5)11-12-22(21)24/h6-12,15-17,20,24H,13-14H2,1-5H3/t20-/m1/s1 |
| InChIKey | OOGJQPCLVADCPB-HXUWFJFHSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | muscarinic antagonist A drug that binds to but does not activate muscarinic cholinergic receptors, thereby blocking the actions of endogenous acetylcholine or exogenous agonists. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| Applications: | muscarinic antagonist A drug that binds to but does not activate muscarinic cholinergic receptors, thereby blocking the actions of endogenous acetylcholine or exogenous agonists. renal agent A drug used for its effect on the kidneys' regulation of body fluid composition and volume. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. muscle relaxant A drug used to produce muscle relaxation (excepting neuromuscular blocking agents). Its primary clinical and therapeutic use is the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. Also used for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in multiple sclerosis. antispasmodic drug A drug that suppresses spasms. These are usually caused by smooth muscle contraction, especially in tubular organs. The effect is to prevent spasms of the stomach, intestine or urinary bladder. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| tolterodine (CHEBI:9622) has functional parent p-cresol (CHEBI:17847) |
| tolterodine (CHEBI:9622) has role analgesic (CHEBI:35480) |
| tolterodine (CHEBI:9622) has role antispasmodic drug (CHEBI:53784) |
| tolterodine (CHEBI:9622) has role muscarinic antagonist (CHEBI:48876) |
| tolterodine (CHEBI:9622) has role muscle relaxant (CHEBI:51371) |
| tolterodine (CHEBI:9622) has role renal agent (CHEBI:35846) |
| tolterodine (CHEBI:9622) is a tertiary amine (CHEBI:32876) |
| Incoming Relation(s) |
| tolterodine tartrate (CHEBI:32245) has part tolterodine (CHEBI:9622) |
| IUPAC Name |
|---|
| 2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-methylphenol |
| INNs | Source |
|---|---|
| tolterodina | WHO MedNet |
| tolterodine | WHO MedNet |
| toltérodine | WHO MedNet |
| tolterodinum | WHO MedNet |
| Synonyms | Source |
|---|---|
| (+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol | ChemIDplus |
| KABI 2234 | ChEMBL |
| KABI-2234 | ChEMBL |
| (+)-Tolterodine | ChemIDplus |
| Tolterodine | KEGG COMPOUND |
| Brand Names | Source |
|---|---|
| Blerone xl | ChEMBL |
| Detrusitol | ChEMBL |
| Detrusitol xl | ChEMBL |
| Efflosomyl xl | ChEMBL |
| Inconex xl | ChEMBL |
| Mariosea xl | ChEMBL |
| Registry Numbers | Sources |
|---|---|
| Beilstein:8070733 | Beilstein |
| CAS:124937-51-5 | ChemIDplus |
| Citations |
|---|